Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Siegfried
Siegfried
Activities:
Manufacturing
Ingredients
Regulatory
Research & Development
Cleaning
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Swiss biomanufacturing sector continues to thrive in 2023
Seigfried, Lonza, ten23 health, Bachem and Dottikon all announce major expansions
Manufacturing
DiNAQOR agrees acquisition to commercialise CGT development and manufacturing platform
Siegfried has made a total investment for the majority acquisition of CDMO DiNAMIQS and the establishment of the new GMP facility that will be in the mid-double-digit millions Swiss Francs
You need to be a subscriber to read this article.
Click here
to find out more.
Manufacturing
Optimising scale-up with flow process technologies
Speed of synthesis is of the essence when medicinal chemists invent new molecules, reports Sarah Houlton
Design & Build
Siegfried acquires three BASF sites
Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy
Media
Siegfried Group sells biologics division
<p>The Siegfried Group, based in Zofingen in Switzerland, is selling its biotechnology business unit to an Indian company, Avesta Biotherapeutics and Research (ABRPL), for an undisclosed sum. </p>
Sharp increase in profits at Siegfried Group
Swiss pharmaceutical company The Siegfried Group has reported its best financial results in its 130-year history.
Subscribe now